Hemerion is focused on creating innovative cancer treatments.
Hemerion has raised $2.8M in total funding. The most recent round was Grant. The last funding was announced in May 2025.
Hemerion's investors include Bpifrance, European Commission, Eurasante, Finovam Gestion, Captech Santé.
Hemerion is headquartered in Villeneuve, France.
Hemerion is focused on creating innovative cancer treatments.
Hemerion is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hemerion — Funding & Investors." VCBacked, May 22, 2025, https://www.vcbacked.co/company/hemerion. Accessed October 20, 2026.
VCBacked. (2025). Hemerion — Funding & Investors. Retrieved October 20, 2026, from https://www.vcbacked.co/company/hemerion
{{cite web |title=Hemerion — Funding & Investors |url=https://www.vcbacked.co/company/hemerion |website=VCBacked |access-date=October 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated